1-1 of 1
Joel Saltzman, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Predictors of Clinical Outcome to Pentostatin, Cyclophosphamide and Rituximab (PCR) Followed by Campath for Relapsed/Refractory CLL – A Study of the Eastern Cooperative Oncology Group, E2903.

Neil E. Kay, MD, Haesook T Kim, PhD., Sanford Kempin, MD, Charla Secreto, Traci Knox, Renee Tschumper, Diane F Jelinek, Stephanie Smoley, Daniel VanDyke, Joel Saltzman, MD, Steven T. Rosen, MD, Brad Kahl, MD, Martin S. Tallman, MD
Journal: Blood
Blood (2008) 112 (11): 1057.
https://doi.org/10.1182/blood.V112.11.1057.1057
Published: 2008